Responses
Diabetes and endocrinology
Protocol
Microvascular Outcomes after Metabolic Surgery (MOMS) in patients with type 2 diabetes mellitus and class I obesity: rationale and design for a randomised controlled trial
Compose a Response to This Article
Other responses
No responses have been published for this article.